financetom
Business
financetom
/
Business
/
Lucid signs deal to raise $1 bln from Saudi's PIF affiliate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lucid signs deal to raise $1 bln from Saudi's PIF affiliate
Mar 25, 2024 5:20 AM

March 25 (Reuters) - Electric automaker Lucid

said on Monday it had signed a deal to raise $1 billion in

funding from an affiliate of Saudi Arabia's Public Investment

Fund.

Ayar Third Investment Company, an affiliate of the sovereign

wealth fund, will buy $1 billion in convertible preferred stock,

the EV maker said.

Shares of the California-based company, which intends to use

the proceeds for corporate purposes among other things, rose

about 4% in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AnaptysBio Q3 collaboration revenue jumps on GSK's Jemperli sales
AnaptysBio Q3 collaboration revenue jumps on GSK's Jemperli sales
Nov 4, 2025
Overview * AnaptysBio ( ANAB ) Q3 collaboration revenue rises significantly due to GSK milestone achievements * Company plans to separate biopharma operations from royalty assets by YE 2026 * AnaptysBio ( ANAB ) reports Q3 net income, contrasting with a loss in the prior year Outlook * AnaptysBio ( ANAB ) plans to separate biopharma operations from royalty assets...
Healthcare REIT LTC Q3 revenue beats expectations, helped by SHOP expansion 
Healthcare REIT LTC Q3 revenue beats expectations, helped by SHOP expansion 
Nov 4, 2025
Overview * LTC Q3 2025 revenue grows significantly, beating analyst expectations * Company reports Q3 net loss due to non-cash write-offs and increased expenses * LTC raises full-year guidance, driven by acquisitions and SHOP outperformance Outlook * Company raises full-year 2025 EPS guidance to $2.45-$2.47 * LTC expects Q4 2025 Core FFO per share of $0.67-$0.69 * Company anticipates closing...
Corcept Therapeutics Q3 Earnings Fall, Revenue Rises; Shares Drop After Hours
Corcept Therapeutics Q3 Earnings Fall, Revenue Rises; Shares Drop After Hours
Nov 4, 2025
05:08 PM EST, 11/04/2025 (MT Newswires) -- Corcept Therapeutics ( CORT ) reported Q3 net income late Tuesday of $0.16 per diluted share, down from $0.41 a year earlier. Four analysts polled by FactSet expected $0.13. Revenue in the three months ended Sept. 30 rose to $207.6 million from $182.5 million a year earlier. Four analysts surveyed by FactSet expected...
PTC Therapeutics Q3 Swings to Profit, Revenue Rises
PTC Therapeutics Q3 Swings to Profit, Revenue Rises
Nov 4, 2025
05:07 PM EST, 11/04/2025 (MT Newswires) -- PTC Therapeutics ( PTCT ) reported Q3 earnings late Tuesday of $0.20 per diluted share, swinging from a loss of $1.39 a year earlier. Analysts polled by FactSet expected a loss of $1.13. Revenue for the three months ended Sept. 30 was $211 million, up from $196.8 million a year earlier. Analysts surveyed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved